Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Melissa Burns, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Sainte Justine, University of Montreal
Montreal, Quebec, Canada
- Centre Hospitalier U. de Quebec
Québec, Quebec, Canada
- Boston Children'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Columbia University Medical Center, Morgan Stanley Children'S Hospital of New York-Presbyterian
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Hasbro Children'S Hospital / Rhode Island Hospital
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Mar 2017
- Primary completion
- 30 Nov 2026
- Completion
- 30 Nov 2034
- Last update posted
- 22 Jan 2026
- Registered enrollment
- 560
- Registry id
- NCT03020030
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.